- Home
- REBN vs NTBL Comparison
REBN vs NTBL Comparison
Compare REBN & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- NTBL
- Stock Information
- Founded
- REBN 2015
- NTBL 2000
- Country
- REBN United States
- NTBL United States
- Employees
- REBN N/A
- NTBL N/A
- Industry
- REBN Restaurants
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- REBN Consumer Discretionary
- NTBL Health Care
- Exchange
- REBN Nasdaq
- NTBL Nasdaq
- Market Cap
- REBN 8.6M
- NTBL 4.6M
- IPO Year
- REBN 2022
- NTBL N/A
- Fundamental
- Price
- REBN $2.30
- NTBL $0.25
- Analyst Decision
- REBN
- NTBL Buy
- Analyst Count
- REBN 0
- NTBL 2
- Target Price
- REBN N/A
- NTBL $5.00
- AVG Volume (30 Days)
- REBN 24.3K
- NTBL 8.1M
- Earning Date
- REBN 11-12-2024
- NTBL 11-12-2024
- Dividend Yield
- REBN N/A
- NTBL N/A
- EPS Growth
- REBN N/A
- NTBL N/A
- EPS
- REBN N/A
- NTBL N/A
- Revenue
- REBN $5,757,858.00
- NTBL $313,000.00
- Revenue This Year
- REBN $163.82
- NTBL N/A
- Revenue Next Year
- REBN $64.55
- NTBL N/A
- P/E Ratio
- REBN N/A
- NTBL N/A
- Revenue Growth
- REBN 42.94
- NTBL 3812.50
- 52 Week Low
- REBN $0.92
- NTBL $0.22
- 52 Week High
- REBN $8.80
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- REBN 31.36
- NTBL 35.14
- Support Level
- REBN $2.34
- NTBL $0.28
- Resistance Level
- REBN $2.87
- NTBL $0.37
- Average True Range (ATR)
- REBN 0.24
- NTBL 0.06
- MACD
- REBN 0.00
- NTBL -0.01
- Stochastic Oscillator
- REBN 21.22
- NTBL 6.26
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.